جست‌وجوی استاد و پژوهشگر

Ryan Hoilandمشاهده پروفایل

استادیار

• Cerebrovascular Physiology
• Hypoxia Research
• Neurocritical Care
• +۳ مورد دیگر

Ryan Hoiland is an Assistant Professor in the Department of Cellular & Physiological Sciences within the Faculty of Medicine at the University of British Columbia. He is part of the Southern Medical Program (SMP) and serves as an Investigator within the Centre for Chronic Disease Prevention and Management (CCDPM). Dr. Hoiland completed his educational journey at the University of British Columbia, earning his BHk (2009-2013), MSc (2013-2015), PhD (2015-2018), and Postdoctoral Fellowship (2018-2023). Dr. Hoiland's research focuses on cerebrovascular physiology and human adaptation to hypoxia. His work investigates how the central nervous system responds to hypoxia in various contexts, including pre-clinical disease models, healthy humans, and patients. Specific areas of interest include the pathophysiology of hypoxic-ischemic brain injury, traumatic spinal cord injury, and strategies for mitigating secondary hypoxic injury. His research spans neurocritical care, cardiac arrest recovery, and high altitude physiology, providing insights into brain oxygenation mechanisms and potential therapeutic interventions. Analysis of Dr. Hoiland's publication record reveals a strong interdisciplinary approach connecting physiology, neurology, and critical care medicine. His work demonstrates consistent focus on cerebral blood flow regulation, oxygen delivery mechanisms, and biomarker development for neurological outcomes following hypoxic events. The research shows progression from basic physiological mechanisms to clinical applications, particularly in cardiac arrest care where understanding the cerebral oxygen cascade has direct patient care implications. Dr. Hoiland maintains an active research laboratory and has indicated that his team is seeking graduate students and postdoctoral fellows, demonstrating ongoing research activity and likely grant funding to support trainees in cerebrovascular physiology research. Dr. Hoiland leads a research laboratory focused on cerebrovascular responses to hypoxia, with particular emphasis on translational applications for patients experiencing brain injury following cardiac arrest or other hypoxic events. The lab appears to utilize both human and pre-clinical models to investigate physiological mechanisms and potential interventions.

Jifeng Zhangمشاهده پروفایل

استاد پژوهشی

• Atherosclerosis
• Vascular Biology
• Cardiovascular Disease
• +۵ مورد دیگر

Jifeng Zhang serves as a Research Professor in the Department of Internal Medicine - Cardiology at the University of Michigan Medical School. His work focuses on cardiovascular research with particular emphasis on atherosclerosis, vascular biology, and metabolic diseases. Dr. Zhang's research interests span multiple areas of cardiovascular medicine and metabolic disorders: Atherosclerosis development and treatment Vascular calcification mechanisms Abdominal and thoracic aortic aneurysm pathophysiology Lipid metabolism and its impact on cardiovascular health Cardiovascular complications of metabolic dysfunction-associated steatohepatitis (MASH) Gene editing applications in cardiovascular research Circadian regulation of blood pressure His recent publication record demonstrates a strong focus on translational cardiovascular research, with particular emphasis on developing novel therapeutic approaches for atherosclerosis and vascular diseases. His work on the tripeptide DT-109 for treating atherosclerosis and fatty liver disease represents a significant advancement in dual-therapy approaches for cardiovascular and metabolic conditions. His research also spans gene editing technologies, as evidenced by his contribution to the EXPERT system for prime editing. Dr. Zhang's research is highly collaborative, working with teams across multiple institutions to advance understanding of vascular pathologies and develop innovative treatments for cardiovascular diseases.

• Cardiovascular Diseases
• Oxidative Stress
• Autophagy
• +۵ مورد دیگر

Valentina Valenti is a Researcher at the Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome . Her work spans cardiovascular diseases, oxidative stress, autophagy, and molecular mechanisms in cardiac remodeling. Specializes in coronary artery disease, heart failure, and environmental influences on cardiovascular health Active in translational research using animal models and clinical cohorts Research Trends Her recent publications focus on: Mitophagy modulation for cardioprotection Autophagy activators (e.g., trehalose) in myocardial infarction Environmental factors (pollution, climate change) influencing cardiovascular events Comparative toxicity of tobacco products using the SUR-VAPES study framework Epigenetic mechanisms in vascular oxidative stress Prognostic imaging tools for coronary artery disease Publications Key themes include coronary artery calcium scoring, vascular dysfunction, and genetic variants affecting thrombosis. Recent work (2025) examines carotid web-related strokes in young patients.

• Medicine
• Pharmacology
• Clinical Pharmacology
• +۵ مورد دیگر

Professor Semra Yiğitaslan is a distinguished faculty member at Eskisehir Osmangazi University, Faculty of Medicine, Department of Medical Pharmacology. She has held academic positions including Lecturer (2014-2016) and Research Assistant (2004-2009), and currently serves as Program Coordinator (2023-present) and Ethics Committee Member (2015-present) within the same institution. Her academic journey began with undergraduate studies (1996-2003) followed by Expertise in Medicine (2004-2009), both completed at Eskisehir Osmangazi University. Professor Yiğitaslan's research spans multiple domains within pharmacology, with particular focus on Medical Pharmacology and Toxicology , Clinical Pharmacology , and Pharmacology and Clinical Pharmacology . Her work frequently investigates drug effects on various organ systems, with significant contributions to understanding chemotherapy-induced toxicities, neuropharmacology, and the therapeutic potential of natural compounds. Her research methodology predominantly employs animal models to explore drug mechanisms and protective interventions. Analysis of her publication record reveals a strong emphasis on experimental pharmacology with consistent output across multiple high-impact journals. Her research trajectory shows sustained focus on understanding drug mechanisms, particularly regarding cyclophosphamide-induced toxicities, oxidative stress pathways, and neuropharmacological effects. The breadth of her work spans from basic medicinal chemistry to clinical applications, demonstrating translational research capabilities. Professor Yiğitaslan has actively contributed to academic service through roles including Publication Committee Member for the Turkish Medical Students Research Journal (2021-present) and Foreign Language Redactor for Osmangazi Medical Journal (2019-2022). She serves as an Associate Member of the Clinical Research Ethics Committee (2014-present) and is a member of the Turkish Pharmacology Association (2005-present). Her supervisory record includes mentoring Master's students M. KIRCADERE (2020) and M. CEMİL (2019). Professor Yiğitaslan has led numerous research projects, particularly focusing on gastrointestinal mucositis, testicular damage, and cardiotoxicity related to chemotherapy agents. Her active participation in scientific conferences and peer review activities demonstrates her engagement with the broader pharmacological community.

Trine Bjøroمشاهده پروفایل

استاد

• Medical Biochemistry
• Thyroid Cancer Diagnostics
• Endocrinology
• +۳ مورد دیگر

Trine Bjøro is a Norwegian Professor of Medical Biochemistry at the Institute of Clinical Medicine, University of Oslo and Senior Consultant/Section Leader at the Department of Medical Biochemistry, Oslo University Hospital . She leads the Thyroid Research Group and is an associate member of the Cancer Marker Research Group. Professor II, Institute of Clinical Medicine, University of Oslo (2007-present) Senior Consultant, Oslo University Hospital (2010-present) PhD in Medical Biochemistry (University of Oslo, 1988) Her research focuses on: Thyroid cancer molecular diagnostics Endocrine late effects in cancer survivors Thyroid epidemiology via the HUNT Study Tumor marker development Immunoassay interference mechanisms Key publication trends: Thyroid dysfunction in testicular cancer survivors HUNT cohort thyroid-cardiovascular risk studies Immunoassay optimization for tumor markers Radiotherapy-induced endocrine disorders Thyroid cancer treatment monitoring She has contributed to 15+ studies spanning: Thyroid hormone-cardiovascular interactions Cancer survivor hormonal monitoring Immunoassay analytical challenges Thyroid cancer biomarker research

Yi Zhangمشاهده پروفایل

دانشیار

• Retinal Diseases
• Ophthalmology
• Gene Therapy
• +۴ مورد دیگر

Yi Zhang is an Associate Professor in the Department of Ophthalmology at the Lewis Katz School of Medicine at Temple University. A clinician-scientist specializing in Retina and Vitreous Diseases, he combines clinical practice with cutting-edge research in gene therapy and laser treatments for retinal conditions. His work spans experimental models of retinal ischemia and corneal regeneration, with over 13 publications analyzed here. Education & Training MD from Zhejiang Medical University, China PhD from Peking Union Medical College, China Vitreo-Retina Fellowship at National Retina Institute, MD Postdoctoral Fellowship at Oregon Health & Science University, OR Ophthalmology Residency at Hahnemann University Hospital, PA and Peking Union Medical College, China Research Focus Dr. Zhang's research explores gene therapy for age-related macular degeneration and other retina diseases. He investigates micropulse subthreshold laser applications for diabetic macular edema, and studies retinal ischemia mechanisms. His experimental work includes rabbit models for retinal surgery and corneal epithelial cell proliferation using growth factors. Scientific Recognition Travel Grant from Association for Research in Vision and Ophthalmology (2006) Pediatric Ophthalmology Research Grant from Knights Templar Eye Foundation (2005) Zhou Zizhuan Scholarship for Outstanding Graduate Students (1999) Award for Distinguished Honor Graduates (1993) Multiple Honor Student Scholarships (1989-1992) Clinical Expertise As a board-certified ophthalmologist with memberships in American Academy of Ophthalmology and American Society of Retinal Specialists, Dr. Zhang treats retinal detachment, diabetic retinopathy, macular holes, and uveitis. His clinical practice spans multiple Temple Health locations including Philadelphia and Fort Washington campuses, with patient satisfaction ratings consistently above 4.7/5 across all metrics.

• Type 2 diabetes
• Hypertension
• Early Vascular Ageing
• +۳ مورد دیگر

Peter M Nilsson is a Researcher at the Department of Clinical Sciences, Malmö , affiliated with Lund University . His work focuses on clinical cardiovascular research, epidemiology, and metabolic diseases. Fields of Interest : Type 2 diabetes, hypertension, early vascular aging, cardiometabolic risk, family heritability studies, and SCAPIS-Extremes research. Research Trends include: studying protective mechanisms against cardiovascular events despite high risk factors (ESCAPER study), early life programming of diseases, and vascular aging in youth. His recent publications emphasize diabetes-cardiovascular interactions, microbiota influences, and population-based cohort analyses. Key collaborative projects : SHIP-CARE (sustainable hypertension in primary care), ESCAPER (cardioprotection), and SCAPIS-Extremes (atherosclerosis resilience). Infrastructure : Manager of the Malmö Population-Based Cohorts Joint Database, enabling large-scale epidemiological studies.

Mary Beth Brownمشاهده پروفایل

دانشیار

• Cardiopulmonary Rehabilitation
• Exercise Physiology
• Lung Disease
• +۵ مورد دیگر

Mary Beth Brown, PT, PhD is an Associate Professor in the Department of Rehabilitation Medicine at the University of Washington School of Medicine. She joined UW in December 2018 after being promoted to Associate Professor with tenure in the Doctor of Physical Therapy program at Indiana University. Prior to academia, Dr. Brown practiced as a licensed physical therapist for nearly a decade in hospital-based outpatient settings. Dr. Brown's educational background includes: Postdoctoral fellowship in Pulmonary and Critical Care at Indiana University School of Medicine PhD in Applied Physiology from Georgia Institute of Technology Master's in Physical Therapy from University of Miami School of Medicine Undergraduate degree in Exercise Science from Lenoir-Rhyne College Dr. Brown directs the Brown Lab for Optimization of Exercise as Therapy in Cardiopulmonary Disease, which focuses on improving how exercise is used as medicine for patients with lung diseases. Her research addresses the gap in data needed to appropriately prescribe exercise for specific patient groups, particularly those with pulmonary arterial hypertension, pulmonary embolism, cystic fibrosis, and lymphangioleiomyomatosis (LAM). Through both clinical and animal studies, her lab defines the physiological and biochemical consequences and functional outcomes following acute and chronic exercise in lung disease to optimize exercise prescription. Her research program is funded by the National Heart, Lung, and Blood Institute of the NIH, The American Heart Association Scientist Development Grant, The Pulmonary Hypertension Association, The American Thoracic Society, and The Lymphangioleiomyomatosis Foundation. Dr. Brown has published extensively on exercise interventions in cardiopulmonary disease, with recent work focusing on mobile health platforms to deliver exercise prescriptions for patients with interstitial lung disease and LAM. Dr. Brown has received several notable awards: New Investigator Award from the American College of Sports Medicine (2016) Cardiovascular & Pulmonary Research Award from the Combined Sections Meeting of the American Physical Therapy Association (2015) 'Emerging Excellence in Research' from the School of Health and Rehabilitation (2014) 2022 Established Investigator Award from The LAM Foundation Dr. Brown mentors numerous students in the Doctor of Physical Therapy program and PhD program in Rehabilitation Science. Her current research projects include "LAMFit," an mHealth program to expand access to exercise benefits for LAM patients, and studies investigating exercise interventions for idiopathic pulmonary fibrosis and Duchenne Muscular Dystrophy. Her lab employs both human clinical studies and rodent models to investigate exercise hemodynamics and physiological responses to acute and chronic exercise.

George Balanosمشاهده پروفایل

دانشیار

• Exercise Physiology
• Respiratory Physiology
• Sleep Medicine
• +۲ مورد دیگر

Dr George Balanos is an Associate Professor in Exercise Physiology at the School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, specializing in respiratory physiology with emphasis on pulmonary blood flow and sleep disordered breathing. He employs advanced ultrasonography for non-invasive physiological measurements and blood gas manipulation techniques in his research. His educational qualifications include: BSc and MSc in Exercise Science and Rehabilitation from City University of New York (1996, 1998) DPhil in Cardiorespiratory Physiology from the University of Oxford (2003) Balanos's research spans Exercise Physiology, Respiratory Physiology, Sleep Medicine, and Environmental Physiology, investigating sleep-exercise interactions in disordered breathing and glucose tolerance, pulmonary circulation control, and breathing regulation during exercise. His methodology involves sophisticated ultrasound imaging and respiratory perturbation systems mimicking high-altitude or pathological conditions. His publication record shows consistent contributions to ventilatory control mechanisms, hypoxia responses, and sleep-metabolism relationships, with recent work exploring cerebral hemodynamics during hypoxia, sleep apnea interventions, and chronotype influences on vascular function. Scientific recognition includes: Excellence in Teaching Award (2008, 2009, 2011, 2019) Outstanding Teaching Award (2008, 2009, 2011, 2019) He supervises PhD candidates Kelsey Joyce (Environmental Physiology), Sultan Alsalahi (Cardiovascular Regulation During Exercise), and Emily Senior (Physical Activity for Sleep Apnoea treatment), with research funding supporting investigations into intermittent hypoxia models, sleep laboratory applications, and cardiopulmonary rehabilitation protocols. His research group operates a dedicated sleep laboratory and advanced ultrasound suite, studying intermittent hypoxia mechanisms in sleep apnea and examining connections between sleep quality, metabolic health, and athletic performance outcomes.

Dick Wågsäterمشاهده پروفایل

استاد

• Vascular Biology
• Inflammatory Diseases
• Cardiovascular Pathophysiology
• +۶ مورد دیگر

Dick Wågsäter is a Professor at the Department of Medical Cell Biology, Uppsala University, leading research on immune cell activation and vascular remodeling in abdominal aortic aneurysm (AAA) . His work spans translational approaches using patient samples, cell culture, and in vivo models to identify novel signaling pathways and drug targets. He also contributes to research on colorectal cancer and cardiovascular implications of genetic polymorphisms . Current research focuses on: Metabolic reprogramming in AAA progression Chemokine and cytokine signaling in vascular inflammation MicroRNA as biomarkers for cardiovascular diseases Pharmacogenomic analysis of metformin's vascular effects His recent publications (2018–2025) emphasize AAA pathogenesis , colorectal cancer genetics , and metabolic-immune interactions . Key collaborators include clinical researchers at Uppsala University Hospital. His group includes doctoral student Levar Shamoun and research assistant Nikiforos Chandrinos . Contact: dick.wagsater@mcb.uu.se | Phone: 018-471 43 96

• Genetics
• Lipoprotein Metabolism
• Familial Hypercholesterolemia
• +۳ مورد دیگر

Jacques Genest, MD, FRCP(C), is a Senior Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) and a Professor in the Department of Medicine at McGill University's Faculty of Medicine and Health Sciences. His research focuses on genetic and metabolic factors in premature coronary artery disease, particularly lipoprotein and apolipoprotein regulation. Research Initiatives: Genetics of low HDL cholesterol states and biogenesis of HDL particles Molecular cellular physiology of cholesterol transport Cardiology/Prevention Clinic for metabolic and genetic factors in coronary disease Founding of the Canadian Familial Hypercholesterolemia (FH) Foundation Publication Trends: Recent works include clinical trials on anti-inflammatory therapies (Canakinumab), systematic reviews on metabolic syndrome and FH prevalence, and guidelines for dyslipidemia management. Key subfields span inflammation, LDL-C reduction, HDL function, and pharmacological interventions for atherosclerosis.

Marcus Pezzolesiمشاهده پروفایل

دانشیار

• Diabetic Nephropathy
• Chronic Kidney Disease
• Diabetes Mellitus
• +۶ مورد دیگر

Marcus Pezzolesi, Ph.D., M.P.H., is Associate Professor of Nephrology and Adjunct Assistant Professor of Human Genetics at the University of Utah School of Medicine. He is a faculty member of the Molecular Biology Program and investigator in the Diabetes and Metabolism Research Center, where his laboratory integrates large-scale sequencing, electronic health records, and genealogical data to dissect the genetic basis of diabetes and kidney disease. Education B.S. – University of Massachusetts Amherst Ph.D. – Ohio State University M.P.H. – Harvard School of Public Health Research Focus Dr. Pezzolesi’s laboratory employs next-generation sequencing, epigenomics, transcriptomics, proteomics, and metabolomics to unravel the molecular mechanisms underlying diabetic nephropathy and chronic kidney disease (CKD). Central themes include: Gene discovery through whole-genome and exome sequencing in families enriched for diabetic kidney disease. Integrative multi-omics to identify circulating microRNAs and proteins as predictive biomarkers of rapid renal decline. Population-specific genetic architecture, particularly in Pacific Islander cohorts, to understand ancestry-driven risk modifiers. Epigenetic regulation (DNA methylation) and its mediation of gene–environment interactions in diabetic complications. Publication Trends Between 2015 and 2025, Dr. Pezzolesi has published more than 60 peer-reviewed papers and conference abstracts. A dominant trend is the progression from candidate gene studies to large-scale genome-wide association and whole-genome sequencing analyses, followed by functional follow-up of identified loci (e.g., FRMD3, FRAS1, ADIPOQ, ASAH2). Recent work expands into environmental epidemiology, integrating air-pollution exposure data with genomic risk to predict diabetic complications. Scientific Awards & Honors No specific awards or honors are listed in the provided text. Grants & Funding While explicit grant numbers are not quoted, the scope and scale of projects—ranging from whole-genome sequencing of >50,000 individuals to multi-ethnic consortia (GENIE, SUMMIT, FinnDiane)—indicate substantial NIH or equivalent funding. Laboratory & Team Dr. Pezzolesi leads a research group within the Diabetes and Metabolism Research Center at the University of Utah, leveraging the Utah Population Database, biobank-linked electronic health records, and state-of-the-art core facilities for genomics, bioinformatics, and molecular phenotyping.

• Vascular Biology
• Cardiac Biology
• Human Aging
• +۳ مورد دیگر

Eric C. Tuday, MD, PhD, is an Assistant Professor in the Department of Internal Medicine, Division of Cardiovascular Medicine at the University of Utah with a joint appointment at the George E. Wahlen Veterans Medical Center. As a board-certified cardiologist, his clinical expertise encompasses general cardiology, echocardiography, cardioversion, hypertension management, nuclear cardiology, and valvular heart disease. Education Background: B.S. in Biomedical Engineering - University of Utah M.S. in Biomedical Engineering - University of Utah Ph.D. in Biomedical Engineering - Johns Hopkins University School of Medicine M.D. - Northwestern University Feinberg School of Medicine Residency in Internal Medicine - Virginia Mason Medical Center Fellowship in Cardiology - Johns Hopkins Medicine Dr. Tuday's research focuses on molecular and cellular mechanisms underlying cardiovascular aging, with particular emphasis on vascular and cardiac biology. His investigations examine how active and passive mechanical properties contribute to abnormal aging processes, including studies on vascular stiffness, microRNA regulation in arterial health, and senolytic therapies targeting age-related cardiovascular decline. His work bridges basic science and clinical applications, exploring translational approaches to age-related cardiovascular disorders. His publication record (15 most recent articles) demonstrates consistent focus on vascular aging mechanisms, with evolving research trajectories from early work on microgravity-induced vascular changes (2009-2011) to contemporary investigations of molecular pathways in vascular stiffness (2019-2024). Recent publications emphasize microRNA regulation, senolytic interventions, and clinical aspects of hypertension in aging populations, reflecting a translational research approach spanning basic mechanisms to therapeutic applications. Scientific awards and honors are not mentioned in the source material. Similarly, no information is available regarding student advising, research grants, or laboratory affiliations beyond his primary institutional appointments. Personal interests include outdoor activities with his dogs such as running, kayaking, paddle boarding, hiking, and skiing.

Sinem Karamanمشاهده پروفایل

دانشیار

• Vascular Biology
• Genetic Engineering
• Obesity
• +۶ مورد دیگر

Sinem Karaman is an Academy Research Fellow and Docent in Cell and Molecular Biology at the University of Helsinki's Faculty of Medicine. She serves as Principal Investigator of the Organotypic Vasculature Lab and supervises doctoral programs in Integrative Life Science and Biomedicine. Education: B.Sc. and M.Sc. in Molecular Biology from Istanbul Technical University (2006, 2008), Ph.D. from ETH Zurich (2012), Docent (2018). Her research focuses on organ-specific blood and lymphatic vasculature in development and disease, with expertise in obesity, diabetes, and inflammation . She applies intravital imaging and single-cell RNA sequencing to study vascular leakage and lymphatic dysfunction. Recent work includes multi-omics analyses of lymphedema-induced adipose tissue , Notch-WNT crosstalk in melanoma metastasis , and VEGFR3 signaling in dural lymphatics . She has published extensively in journals like Nature Cardiovascular Research and Cell Reports Medicine . Scientific Awards: Academy Research Fellow (2020) Early Career Researcher (2018) Research Grant (2018) Travel Award for Poster (2018) She leads projects funded by the Sigrid Jusélius Foundation , Finska Läkaresällskapet , and Åland Foundations , focusing on lymphatic regulation in metabolic diseases and adipose tissue dysfunction . Her lab supervises doctoral theses and collaborates internationally.

Colin Brownمشاهده پروفایل

مدرس ارشد

• Neuroscience
• Physiology
• Hypertension
• +۳ مورد دیگر

Colin Brown serves as an Honorary Senior Lecturer in Health Policy and Governance at the School of Medicine, University of St Andrews, United Kingdom. His academic profile bridges laboratory neuroscience with health policy frameworks, maintaining active research affiliations while operating under an honorary academic appointment. Dr. Brown's research concentrates on neurophysiological mechanisms of hypertension , with particular expertise in vasopressin/oxytocin neuronal regulation, baroreflex pathways, and sympathetic nervous system control. His work integrates molecular neuroscience with cardiovascular physiology to investigate salt-sensitive hypertension and neural plasticity in disease states. Key methodologies include rat disease models and electrophysiological analysis of neuroendocrine pathways. Analysis of his publication record (2014-2015) reveals a cohesive research trajectory examining hypertension pathogenesis through neural control systems. His studies consistently address impaired baroreflex function, vasopressin neuron dysregulation, and sympathetic overactivity, generating significant academic attention with coverage across 13 news outlets, 28 X posts, and 1,130 Mendeley readers. This work demonstrates translational relevance connecting basic neurophysiology to clinical hypertension management.